EuroPCR 2025 | EMPOWER CAD

Women are underrepresented in numerous percutaneous transluminal coronary angioplasty (PTCA) studies, particularly in those analyzing calcified or high-risk lesions. This leads to worse clinical outcomes for this group.

Researchers conducted an analysis on 389 women with severely calcified coronary lesions who were treated with coronary lithotripsy.

The average age was 73 years; 46% of subjects had diabetes, 32% had a history of myocardial infarction, 38% had undergone prior PTCA, and 28% had impaired renal function.

Additionally, 46% had stable coronary syndrome, 24% had non-ST-elevation myocardial infarction (NSTEMI), while unstable angina and ST-elevation myocardial infarction (STEMI) were less frequent.

At 30 days, cardiac mortality was 1.3%, the infarction rate was 10.6%, and the target lesion revascularization (TLR) rate was 1.3%. There was a significant improvement in quality of life.

Presented by Margaret McEntergart during EuroPCR 2025 in Paris, France.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...